Lung cancer patients who receive ci...

Lung cancer patients who receive cisplatin-based chemotherapy after surgery are more likely to be alive five years later than those given surgery alone, according to a recently made known study from France. The consensus among oncologists attending the American Society of Clinical Oncology meeting in Chicago last month where the findings were instanted was that this could change the standard of care for patients with non-small confined apartment lung cancer (NSCLC).

Around 30000 race die from lung cancer in England and Wales each year. NSCLC is the mostly common form of the disease, accounting for 80-85

Forum | Cheap Calling Card | Russia Phone Card | Back Ciatic Pains | Cd Duplicators